Exploring regulated cell death in renal cell carcinoma: mechanistic insights and therapeutic perspectives
Apoptosis · 2026
DOI: 10.1007/s10495-026-02425-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Apoptosis, 2026. Verfasst von Guanyu Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No.1665 Kongjiang Road, Shanghai, 200092, Chin…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Regulated Cell Death. Die Arbeit nennt 146 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shanghai Leading Talent Program Project.
Abstract (Originalsprache)
Renal cell carcinoma (RCC) is the third most prevalent urological malignancy, characterized by histological heterogeneity and complex molecular landscapes. Although established regimens, including surgical intervention, targeted therapies and immunotherapy, effectively manage early-stage disease, patients with advanced RCC still have a poor prognosis. The expanding spectrum of regulated cell death (RCD), ranging from established apoptosis and ferroptosis to emerging modalities like cuproptosis, disulfidptosis and ammonia-induced cell death, offers novel mechanistic insights into tumor vulnerabilities. This tumor progression and subsequent therapeutic resistance are substantially mediated by dysregulated networks of RCD. To systematically deconstruct this mechanistic complexity, this review stratifies RCD into three specific functional dimensions: precise protein signaling, intracellular homeostasis dysregulation, and physiological dysfunction. Because RCC intrinsically evades cascade-governed pathways such as apoptosis to survive immune elimination, its inherent metabolic reprogramming concomitantly creates paradoxical vulnerabilities. Consequently, these tumors exhibit profound susceptibility to homeostasis-disrupting modalities like ferroptosis, cuproptosis, disulfidptosis, and ammonia-induced cell death. Extending this mechanistic framework beyond clear cell RCC (ccRCC), we define the unique metabolic and redox dependencies of underrepresented non-clear cell variants, including papillary RCC (pRCC), chromophobe RCC (chRCC), fumarate hydratase (FH)-deficient RCC and TFE3-rearranged RCC. By evaluating current RCD-targeted pharmacological interventions, this review highlights critical opportunities to exploit these functional dependencies, offering rational approaches to overcome intrinsic resistance and complement existing therapies. Ultimately, integrating this multidimensional RCD framework with multi-omics profiling facilitates a deeper biological understanding of renal tumors and provides a necessary foundation to accelerate the development of precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No.1665 Kongjiang Road, Shanghai, 200092, China.
- Department of Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No.1665 Kongjiang Road, Shanghai, 200092, China. lyf0501@sjtu.edu.cn.
- Department of Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No.1665 Kongjiang Road, Shanghai, 200092, China. cuixingang@xinhuamed.com.cn.
- Department of Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No.1665 Kongjiang Road, Shanghai, 200092, China. panxiuwu@126.com.
ORCID-Profile: Xiuwu Pan
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Shanghai Leading Talent Program Project
- the Natural Science Foundation of Shanghai
- Shanghai Rising-Star Program
- Shanghai Oriental Talent Plan Youth Program
- "Cross-Fund Project" of Xinhua Hospital
Zitieren
APA
Zhu, G., Zhang, H., Li, Y., Ma, W., Yao, Y., Lyu, D., Lu, B., Zong, Y., Dong, K., Zhou, W., Liu, Y., Cui, X., & Pan, X. (2026). Exploring regulated cell death in renal cell carcinoma: mechanistic insights and therapeutic perspectives. Apoptosis. https://doi.org/10.1007/s10495-026-02425-9
Vancouver
Zhu G, Zhang H, Li Y, Ma W, Yao Y, Lyu D, et al. Exploring regulated cell death in renal cell carcinoma: mechanistic insights and therapeutic perspectives. Apoptosis. 2026. doi:10.1007/s10495-026-02425-9
BibTeX
@article{Zhu2026,
author = {Zhu, Guanyu and Zhang, Hangbiao and Li, Yuanan and Ma, Wenjie and Yao, Yuntao and Lyu, Donghao and Lu, Bingnan and Zong, Yuanbo and Dong, Keqin and Zhou, Wang and Liu, Yifan and Cui, Xingang and Pan, Xiuwu},
title = {Exploring regulated cell death in renal cell carcinoma: mechanistic insights and therapeutic perspectives},
journal = {Apoptosis},
year = {2026},
doi = {10.1007/s10495-026-02425-9}
}
EUVIMED